HANNAH BAILEY: Open Payments
NPI 1760190201 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 21 payments from 9 companies in 2025. Trend: 2023 $694 · 2024 $995 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $218 |
| Novo Nordisk Inc | 4 | $67 |
| Lilly USA, LLC | 3 | $55 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| ABBVIE INC. | 2 | $28 |
| Verona Pharma, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: BREZTRI, FARXIGA, MOUNJARO, Ozempic, Wegovy, TRELEGY ELLIPTA, VRAYLAR, Ohtuvayre.
Industry payments across NC — which companies pay providers there.
